nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer
|
Olivo, Malini |
|
2012 |
30 |
5 |
p. 624-634 11 p. |
artikel |
2 |
Analysis of energy utilization and body composition in kidney, bladder, and adrenal cancer patients
|
Xu, Wen P. |
|
2012 |
30 |
5 |
p. 711-718 8 p. |
artikel |
3 |
Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: A novel approach using peptide nucleic acid-mediated, real-time PCR clamping
|
Kim, Eun-Jung |
|
2012 |
30 |
5 |
p. 673-679 7 p. |
artikel |
4 |
Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy
|
Mucksavage, Phillip |
|
2012 |
30 |
5 |
p. 590-595 6 p. |
artikel |
5 |
Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?
|
Mandal, Raju Kumar |
|
2012 |
30 |
5 |
p. 555-561 7 p. |
artikel |
6 |
Clinical characteristics of bladder urothelial tumors in male patients—the influences of benign prostatic hyperplasia/benign prostatic enlargement
|
Zhang, Nian-zhao |
|
2012 |
30 |
5 |
p. 646-651 6 p. |
artikel |
7 |
Commentary on “Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A meta-analysis of randomized trials.” Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK, Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
|
Trump, Donald L. |
|
2012 |
30 |
5 |
p. 746-747 2 p. |
artikel |
8 |
Commentary on “Comparative effectiveness of axitinib vs. sorafenib in advanced renal cell carcinoma (AXIS): A randomized phase 3 trial.” B.I. Rini, B. Escudier, P. Tomczak, A. Kaprin, C. Szczylik, T.E. Hutson, M.D. Michaelson, V.A. Gorbunova, M.E. Gore, I.G. Rusakov, S. Negrier, Y.C. Ou, D. Castellano, H.Y. Lim, H. Uemura, J. Tarazi, D. Cella, C. Chen, B. Rosbrook, S. Kim, R.J. Motzer
|
Trump, Donald L. |
|
2012 |
30 |
5 |
p. 748- 1 p. |
artikel |
9 |
Commentary on “Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: Results of a phase 3, randomized, placebo-controlled trial.” M.R. Smith, F. Saad, R. Coleman, N. Shore, K. Fizazi, B. Tombal, K. Miller, P. Sieber, L. Karsh, R. Damião, T.L. Tammela, B. Egerdie, H. Van Poppel, J. Chin, J. Morote, F. Gómez-Veiga, T. Borkowski, Z. Ye, A. Kupic, R. Dansey, C. Goessl, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
|
Trump, Donald L. |
|
2012 |
30 |
5 |
p. 747- 1 p. |
artikel |
10 |
Commentary on “Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer.” A.V. D'Amico, M.H. Chen, J. Crook, J.G. Armstrong, S. Malone, A. Steigler, M. Dunne, P.W. Kantoff, J.W. Denham, Brigham and Women's Hospital, Boston, MA. 02115, USA.
|
Trump, Donald L. |
|
2012 |
30 |
5 |
p. 746- 1 p. |
artikel |
11 |
Commentary on “Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localized or locally advanced prostate cancer: An analysis of 2 randomized trials.” A.V. D'Amico, M.H. Chen, M. de Castro, M. Loffredo, D.S. Lamb, A. Steigler, P.W. Kantoff, J.W. Denham, Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA
|
Trump, Donald L. |
|
2012 |
30 |
5 |
p. 745- 1 p. |
artikel |
12 |
Contents
|
|
|
2012 |
30 |
5 |
p. vi-viii nvt p. |
artikel |
13 |
Course of size and density of metastatic renal cell carcinoma lesions in the early follow-up of molecular targeted therapy
|
Hittinger, Markus |
|
2012 |
30 |
5 |
p. 695-703 9 p. |
artikel |
14 |
Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR)
|
Sciarra, Alessandro |
|
2012 |
30 |
5 |
p. 614-619 6 p. |
artikel |
15 |
Editorial Board
|
|
|
2012 |
30 |
5 |
p. v- 1 p. |
artikel |
16 |
External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy series
|
Loeb, Stacy |
|
2012 |
30 |
5 |
p. 584-589 6 p. |
artikel |
17 |
Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder
|
Bi, Jianbin |
|
2012 |
30 |
5 |
p. 688-694 7 p. |
artikel |
18 |
HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: A pilot study
|
Asimakopoulos, Anastasios D. |
|
2012 |
30 |
5 |
p. 577-583 7 p. |
artikel |
19 |
Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach
|
Zhang, Hongyong |
|
2012 |
30 |
5 |
p. 635-645 11 p. |
artikel |
20 |
Information for Authors
|
|
|
2012 |
30 |
5 |
p. IBC- 1 p. |
artikel |
21 |
Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer
|
Hara, Noboru |
|
2012 |
30 |
5 |
p. 596-601 6 p. |
artikel |
22 |
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma
|
Fritsche, Hans-Martin |
|
2012 |
30 |
5 |
p. 666-672 7 p. |
artikel |
23 |
Masthead
|
|
|
2012 |
30 |
5 |
p. iv- 1 p. |
artikel |
24 |
Overview
|
Platz, Elizabeth A. |
|
2012 |
30 |
5 |
p. 727-728 2 p. |
artikel |
25 |
Physical activity and urologic cancers
|
Wolin, Kathleen Y. |
|
2012 |
30 |
5 |
p. 729-734 6 p. |
artikel |
26 |
Plagiarism
|
Droller, Michael J. |
|
2012 |
30 |
5 |
p. 547-548 2 p. |
artikel |
27 |
Polymorphisms of glutathione S-transferase μ and θ, MDR1 and VEGF genes as risk factors of bladder cancer: A case-control study
|
Henríquez-Hernández, Luis Alberto |
|
2012 |
30 |
5 |
p. 660-665 6 p. |
artikel |
28 |
Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma
|
Lin, Chang-Te |
|
2012 |
30 |
5 |
p. 680-687 8 p. |
artikel |
29 |
Prostate biopsy in patients with long-term use of indwelling bladder catheter: What is the rationale?
|
Antunes, Alberto A. |
|
2012 |
30 |
5 |
p. 620-623 4 p. |
artikel |
30 |
Prostate cancer chemoprevention with 5α-reductase inhibitors
|
Nepple, Kenneth G. |
|
2012 |
30 |
5 |
p. 553-554 2 p. |
artikel |
31 |
Prostate-specific antigen response after definitive radiotherapy for Skene's gland adenocarcinoma resembling prostate adenocarcinoma
|
Korytko, Timothy P. |
|
2012 |
30 |
5 |
p. 602-606 5 p. |
artikel |
32 |
Robotic-assisted vs. open radical prostatectomy: When can we stop the debate?
|
Lavery, Hugh J. |
|
2012 |
30 |
5 |
p. 549-552 4 p. |
artikel |
33 |
Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy
|
Sonpavde, Guru |
|
2012 |
30 |
5 |
p. 607-613 7 p. |
artikel |
34 |
Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway
|
Ping, Szu-Yuan |
|
2012 |
30 |
5 |
p. 652-659 8 p. |
artikel |
35 |
Survey Section Editorial Board
|
|
|
2012 |
30 |
5 |
p. 744- 1 p. |
artikel |
36 |
The effect of minimally invasive and open radical prostatectomy surgeon volume
|
Choi, Wesley W. |
|
2012 |
30 |
5 |
p. 569-576 8 p. |
artikel |
37 |
The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study
|
Baldazzi, Valentina |
|
2012 |
30 |
5 |
p. 704-710 7 p. |
artikel |
38 |
The predominance of benign histology in small testicular masses
|
Shilo, Yaniv |
|
2012 |
30 |
5 |
p. 719-722 4 p. |
artikel |
39 |
The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells
|
Ku, Ja Hyeon |
|
2012 |
30 |
5 |
p. 562-568 7 p. |
artikel |
40 |
Utility of 18F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes
|
Rosevear, Henry M. |
|
2012 |
30 |
5 |
p. 723-726 4 p. |
artikel |
41 |
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence
|
Pierce, Brandon L. |
|
2012 |
30 |
5 |
p. 735-743 9 p. |
artikel |